NCT06463626View on ClinicalTrials.gov

Real-life Treatment Patterns With Cyclin-dependent Kinase Inhibitors in Advanced Breast Cancer in Portugal - REVEAL Study

CompletedOBSERVATIONAL
Enrollment

121

Participants

Timeline

Start Date

April 6, 2020

Primary Completion Date

June 27, 2023

Study Completion Date

June 27, 2023

Conditions
Hormone-receptor-positive Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast
Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY